-
公开(公告)号:USH1662H
公开(公告)日:1997-07-01
申请号:US519280
申请日:1990-04-05
申请人: Osamu Nishimura , Masahiko Fujino
发明人: Osamu Nishimura , Masahiko Fujino
IPC分类号: C07K14/655 , A61K35/74 , A61K38/00 , A61K38/16 , A61K38/21 , A61K38/28 , C07K1/107 , C07K1/113 , C07K14/00 , C07K14/52 , C07K14/54 , C07K14/55 , C07K14/555 , C07K14/56 , C07K14/57 , C07K14/575 , C07K14/585 , C07K14/60 , C07K14/62 , C07K17/08 , C08H1/00 , C12N15/00 , C12N15/09 , A61K38/20
摘要: The invention provides chemically modified lymphokines comprising a lymphokine moiety and at least one polyethylene glycol moiety of the formula: R.paren open-st.O--CH.sub.2 CH.sub.2 .paren close-st..sub.n wherein R is a protective group for the terminal oxygen and n is at least one, bonded directly to at least one primary amino group of the lymphokine moiety, and a method of producing the same.The chemically modified lymphokines according to the invention can be produced by reacting a lymphokine with an aldehyde of the formula R.paren open-st.O--CH.sub.2 CH.sub.2 .paren close-st..sub.n-1 O--CH.sub.2 CHO wherein R and n are as defined above, in the presence of a reducing agent.The chemically modified lymphokines according to the invention are useful as drugs, among others.
摘要翻译: 本发明提供化学修饰的淋巴因子,其包含淋巴因子部分和至少一个下式的聚乙二醇部分:R + 545 O-CH 2 CH 2 + 546 n其中R是末端氧的保护基,n是至少一个,直接键合到 淋巴因子部分的至少一个伯氨基及其制备方法。 根据本发明的化学修饰的淋巴因子可以通过使淋巴因子与式R + 545 O-CH2CH2 + 546n-10-CH2CHO的醛反应来制备,其中R和n如上定义,在还原剂 。 根据本发明的化学修饰的淋巴因子可用作药物等。
-
公开(公告)号:US4368150A
公开(公告)日:1983-01-11
申请号:US233641
申请日:1981-02-11
申请人: Masahiko Fujino , Osamu Nishimura
发明人: Masahiko Fujino , Osamu Nishimura
IPC分类号: C07K1/06 , C07K7/23 , C07C103/52 , C07C147/13
摘要: A guanidino group in an amino acid or a peptide can be protected with a specific group, i.e. pentamethylbenzensulfonyl, 2,4,6-trimethoxybenzenesulfonyl, 4-methoxy-2,3,5,6-tetramethylbenzenesulfonyl, 4-methoxy-2,6-dimethylbenzenesulfonyl or 4-methoxy-2,3,6-trimethylbenzenesulfonyl, and said group may easily be removed without affecting the amino acid or the peptide to be derived from the protected amino acid or peptide. Thus, the present invention is useful in the synthesis of peptides containing the guanidino group.
摘要翻译: 氨基酸或肽中的胍基可以用特定的基团来保护,即五甲基苯磺酰基,2,4,6-三甲氧基苯磺酰基,4-甲氧基-2,3,5,6-四甲基苯磺酰基,4-甲氧基-2,6 二甲基苯磺酰基或4-甲氧基-2,3,6-三甲基苯磺酰基,并且所述基团可以容易地除去而不影响衍生自被保护的氨基酸或肽的氨基酸或肽。 因此,本发明可用于合成含有胍基的肽。
-
公开(公告)号:US4229438A
公开(公告)日:1980-10-21
申请号:US36988
申请日:1979-05-07
申请人: Masahiko Fujino , Osamu Nishimura , Muneo Takaoki
发明人: Masahiko Fujino , Osamu Nishimura , Muneo Takaoki
IPC分类号: A61K38/00 , A61K38/22 , A61P37/00 , C07K5/06 , C07K5/083 , C07K5/103 , C07K7/06 , A61K37/00 , C07C103/52
CPC分类号: C07K7/06 , C07K5/06069 , C07K5/081 , C07K5/1013 , A61K38/00 , Y02P20/55 , Y10S514/885 , Y10S930/18
摘要: Novel nonapeptides of the formula:pGlu-X-Lys-Ser-Gln-Y-Z-Ser-Asn-OHwherein X is Ala or (D)-Ala; Y and Z are the same or different and each is the residue of a D-amino acid containing 3 to 9 carbon atoms, or Gly; and at least one of X, Y and Z is the residue of D-amino acid, have immunoregulator activity and are of value as medicines.
摘要翻译: 新的具有下列通式的肽:pGlu-X-Lys-Ser-Gln-Y-Z-Ser-Asn-OH其中X是Ala或(D)-Ala; Y和Z相同或不同,分别为含有3〜9个碳原子的D-氨基酸或Gly; X,Y和Z中的至少一个是D-氨基酸的残基,具有免疫调节剂活性,作为药物有价值。
-
公开(公告)号:US4100152A
公开(公告)日:1978-07-11
申请号:US778321
申请日:1977-03-16
申请人: Masahiko Fujino , Osamu Nishimura , Yuji Nagawa , Naohisa Fukuda
发明人: Masahiko Fujino , Osamu Nishimura , Yuji Nagawa , Naohisa Fukuda
IPC分类号: C07K14/575 , A61K38/04 , A61P5/00 , A61P25/26 , C07D279/12 , C07D307/33 , C07K5/06 , C07K5/097 , C07C103/52 , A61K37/00
CPC分类号: C07D307/33 , C07D279/12 , C07K5/0821
摘要: A novel peptide of the formula: ##STR1## wherein A is hydrogen, alkyl, aralkyl, alkoxyalkyl, hydroxyalkyl or alkoxy; R is ##STR2## X is --S-- or --(CH.sub.2).sub.n -- where n is 1 or 2 has a weaker TRH releasing activity than TRH and a stronger anaesthesia-antagonistic activity, spontaneous movement-stimulant activity or dopamine-potentiating activity than TRH.
摘要翻译: 一种下式的新肽:其中A是氢,烷基,芳烷基,烷氧基烷基,羟基烷基或烷氧基; R是X - 为-S-或 - (CH2)n-,其中n为1或2具有比TRH更弱的TRH释放活性和更强的麻醉 - 拮抗活性,自发运动刺激活性或多巴胺增强活性, TRH。
-
5.
公开(公告)号:US3959245A
公开(公告)日:1976-05-25
申请号:US345328
申请日:1973-03-27
申请人: Nobuo Nakajima , Hisashi Aoki , Masahiko Fujino , Osamu Nishimura , Mitsuhiro Wakimasu , Mitsuhiko Mano
发明人: Nobuo Nakajima , Hisashi Aoki , Masahiko Fujino , Osamu Nishimura , Mitsuhiro Wakimasu , Mitsuhiko Mano
IPC分类号: A23L27/30 , C07K5/072 , C07K5/075 , A23L1/22 , C07C103/52
CPC分类号: C07K5/06113 , A23L27/32 , Y10S530/801
摘要: A novel dipeptide, L-aspartyl-aminomalonic acid methyl 2-methylcyclohexyl diester and its physiologically acceptable salts which are useful as a sweetener, and production thereof and sweetening compositions containing the dipeptide or its salt.
摘要翻译: 可用作甜味剂的新型二肽,L-天冬氨酰基 - 氨基马来酸甲基2-甲基环己基二酯及其生理学上可接受的盐及其生产物和含有二肽或其盐的甜味组合物。
-
公开(公告)号:US4487726A
公开(公告)日:1984-12-11
申请号:US420710
申请日:1982-09-21
申请人: Masahiko Fujino , Osamu Nishimura
发明人: Masahiko Fujino , Osamu Nishimura
IPC分类号: C07K1/06 , C07K7/23 , C07C143/70
摘要: A guanidino group in an amino acid or a peptide can be protected with a specific group, i.e. pentamethylbenzenesulfonyl, 2,4,6-trimethoxybenzenesulfonyl, 4-methoxy-2,3,5,6-tetramethylbenzenesulfonyl, 4-methoxy-2,6-dimethylbenzenesulfonyl or 4-methoxy-2,3,6-trimethylbenzenesulfonyl, and said group may easily be removed without affecting the amino acid or the peptide to be derived from the protected amino acid or peptide. Thus, the present invention is useful in the synthesis of peptides containing the guanidino group.
-
公开(公告)号:US4111924A
公开(公告)日:1978-09-05
申请号:US805900
申请日:1977-06-13
申请人: Masahiko Fujino , Osamu Nishimura , Chieko Kitada
发明人: Masahiko Fujino , Osamu Nishimura , Chieko Kitada
CPC分类号: C07K5/1013 , C07K1/067 , C07K1/12 , C07K5/0806 , C07K5/1019 , Y02P20/55 , Y10S930/15 , Y10S930/16
摘要: A novel method for removal of protective group(s) from an amino acid or peptide having thiol group(s) protected with p-methoxybenzyl, 1-adamantyl or t-butyl group by treating the protected amino acid or peptide with the mercuric salt of acetic acid or halogenoacetic acid, the removal being effected selectively and very smoothly in a good yield under extremely mild conditions without giving any undesirable influence upon other functional or protective group(s).
-
公开(公告)号:US5109120A
公开(公告)日:1992-04-28
申请号:US364707
申请日:1989-06-09
申请人: Hayao Ueno , Masahiko Fujino
发明人: Hayao Ueno , Masahiko Fujino
IPC分类号: A61K38/00 , C07C67/00 , C07C241/00 , C07C251/08 , C07K1/00 , C07K1/107 , C07K1/113 , C07K14/00 , C07K14/195 , C07K14/41 , C07K14/52 , C07K14/54 , C07K14/55 , C07K14/555 , C07K14/56 , C07K14/57 , C12P21/00 , C12P21/02 , C12R1/19
CPC分类号: C07K14/55 , C07K1/1077 , C07K14/555 , C07K14/56 , A61K38/00
摘要: The invention provides chemically modified proteins having a group of the formula: ##STR1## wherein R represents a hydrogen atom or a lower alkyl, m represents an optional positive integer and n represents an integer 1 to 4, the group being bonded to at least one primary amino group of the protein, and a method of producing the same. The chemically modified proteins according to the invention can be produced by reacting a protein with an imidoester of the formula: ##STR2## wherein R, n and m are as defined above, R' represents a group constituting an imidoester with an adjacent imidoyl group. The chemically modified proteins according to the invention are useful as drugs, among others.
摘要翻译: 本发明提供具有下式基团的化学修饰的蛋白质:其中R表示氢原子或低级烷基,m表示任选的正整数,n表示1至4的整数,该基团与至少一个 该蛋白质的伯氨基及其制备方法。 根据本发明的化学修饰的蛋白质可以通过使蛋白质与下式的亚胺酯反应来制备:其中R,n和m如上定义,R'代表构成具有相邻亚氨基的亚氨基酯基团。 根据本发明的化学修饰的蛋白质可用作药物等。
-
公开(公告)号:US4073890A
公开(公告)日:1978-02-14
申请号:US726052
申请日:1976-09-23
CPC分类号: C07K5/1019 , C07K14/62 , C07K5/0812 , A61K38/00
摘要: Novel polypeptides of the formulaR.sub.1 --Arg--R.sub.2 --Phe--Phe--R.sub.3wherein R.sub.1 is hydrogen, or a basic or neutral amino acid residue, R.sub.2 is a neutral amino acid residue and R.sub.3 is NH.sub.2, Tyr--NH.sub.2, a residue of tyrosyl peptides consisting of 1 to 5 amino acid residues or amides of the tyrosyl peptides, provided that when R.sub.1 is hydrogen, R.sub.2 is Pro, are effectively used for treatment of insufficiency of carbohydrate metabolism and of lipid metabolism, especially for the treatment of diabetes by not only parenteral administration but also oral administration.
摘要翻译: 式R1-Arg-R2-Phe-Phe-R3的新型多肽,其中R1是氢,或碱性或中性氨基酸残基,R2是中性氨基酸残基,R3是NH2,Tyr-NH2,酪氨酰基的残基 由酪氨酰肽的1至5个氨基酸残基或酰胺组成的肽,条件是当R1为氢时,R2为Pro,可有效用于治疗碳水化合物代谢和脂质代谢不足,特别是用于治疗糖尿病 只有肠胃外给药,而且口服。
-
10.
公开(公告)号:US4001199A
公开(公告)日:1977-01-04
申请号:US560092
申请日:1975-03-19
IPC分类号: C07K7/06 , A61K38/00 , A61K38/04 , A61K38/28 , A61P3/10 , C07K5/097 , C07K5/11 , C07K14/62 , C07C103/52 , A61K37/00
CPC分类号: C07K14/62 , C07K5/0821 , A61K38/00
摘要: Novel polypeptides of the formulaR.sub.1 --Arg--R.sub.2 --Phe--Phe--R.sub.3wherein R.sub.1 is hydrogen, or a basic or neutral amino acid residue, R.sub.2 is a neutral amino acid residue and R.sub.3 is NH.sub.2, Tyr--NH.sub.2, a residue of tyrosyl peptides consisting of 1 to 5 amino acid residues or amides of the tyrosyl peptides, provided that when R.sub.1 is hydrogen, R.sub.2 is Pro, are effectively used for treatment of insufficiency of carbohydrate metabolism and of lipid metabolism, especially for the treatment of diabetes by not only parenteral administration but also oral administration.
摘要翻译: 式R1-Arg-R2-Phe-Phe-R3的新型多肽,其中R1是氢,或碱性或中性氨基酸残基,R2是中性氨基酸残基,R3是NH2,Tyr-NH2,酪氨酰基的残基 由酪氨酰肽的1至5个氨基酸残基或酰胺组成的肽,条件是当R1为氢时,R2为Pro,可有效用于治疗碳水化合物代谢和脂质代谢不足,特别是用于治疗糖尿病 只有肠胃外给药,而且口服。
-
-
-
-
-
-
-
-
-